Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
OptiMedica's photocoagulator now available for international sale
OptiMedica Corp.’s Pascal Photocoagulator is now available for international sale, because of the company’s recent ISO 13485 certification and CE Mark approval.
OptiMedica Corp.’s Pascal Photocoagulator is now available for international sale, because of the company’s recent ISO 13485 certification and CE Mark approval.
The first Pascal systems outside of the United States will be placed at key practices in Japan and Europe.
The company immediately will begin working with leading international ophthalmologists to establish a new standard of care in the treatment of retinal diseases.
Related Videos
Related Content
